Cy7-conjugated antibodies are critical tools in:
Detection of surface markers (e.g., CD3, CD14, CD19) with high sensitivity due to minimal spectral overlap .
Example: PE/Cyanine7 anti-human CD14 (Clone 61D3) shows >90% staining efficiency in human peripheral blood mononuclear cells .
Used in paraffin-embedded and frozen sections for subcellular localization studies (e.g., cytokeratin 7 detection in bile duct epithelia ).
Anti-CD7 antibodies conjugated to Cy7 analogs (e.g., J87-Dxd ADC) showed:
VRC07-523LS (a CD4-binding site antibody) engineered with extended half-life (42 days vs. 15 days for VRC01) used Cy7 analogs for pharmacokinetic tracking .
Cytochrome c antibodies (Clone 7H8.2C12) conjugated to biotin/Cy7 detected 15 kDa bands in HeLa lysates, confirming mitochondrial localization .
Bioavailability: Intravenous administration yields higher serum concentrations than subcutaneous routes (e.g., 20 mg/kg IV vs. 5 mg/kg SC ).